142 related articles for article (PubMed ID: 3123757)
1. Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.
Shigaki N; Kimura M; Takano S; Fujino N; Akagi M
Jpn J Surg; 1987 Sep; 17(5):395-401. PubMed ID: 3123757
[TBL] [Abstract][Full Text] [Related]
2. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Waseda N; Kato Y; Matsushita N; Imura H
Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151
[TBL] [Abstract][Full Text] [Related]
3. Priming action on progesterone receptor synthesis by estradiol and tamoxifen in the 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma.
Boccardo F; Cerruti G; De Menech R; Valenti G; Zanardi S
Oncology; 1987; 44(4):248-52. PubMed ID: 3112670
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
6. Effects of OK-432 (Picibanil) on estrogen receptor levels and tamoxifen treatment in 7,12-dimethylbenz[a]anthracene-induced rat mammary cancers.
Iino Y; Ogawa T; Yoshida M; Izuo M; Takikawa H
Oncology; 1990; 47(2):185-90. PubMed ID: 2107482
[TBL] [Abstract][Full Text] [Related]
7. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
9. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
10. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
11. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
Muldoon TG
Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
[TBL] [Abstract][Full Text] [Related]
12. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
Gandilhon P; Melancon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
[TBL] [Abstract][Full Text] [Related]
14. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
Labrie F; Kelly PA; Asselin J; Raynaud JP
Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798
[TBL] [Abstract][Full Text] [Related]
16. Changes in the hormone dependency of DMBA-induced rat mammary tumors with reference to the effect of tamoxifen.
Inui K; Morimoto T; Komaki K; Sonoo H; Monden Y
Jpn J Surg; 1988 May; 18(3):284-90. PubMed ID: 3136267
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
[TBL] [Abstract][Full Text] [Related]
18. Close correlation between progesterone receptor concentration and hormonal sensitivity in DMBA-induced mammary tumours of the rat.
Mobbs BG
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):835-42. PubMed ID: 6409617
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-17 beta as an initiation modifier for radiation-induced mammary tumorigenesis of rats ovariectomized before puberty.
Inano H; Yamanouchi H; Suzuki K; Onoda M; Wakabayashi K
Carcinogenesis; 1995 Aug; 16(8):1871-7. PubMed ID: 7634417
[TBL] [Abstract][Full Text] [Related]
20. Effects of trilostane on 7,12-dimethylbenz[a]anthracene-induced rat mammary cancers and body weight of rats in relation to estrogen receptors.
Iino Y; Izuo M; Takikawa H
Oncology; 1989; 46(5):301-5. PubMed ID: 2506498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]